Skip to content
The Policy VaultThe Policy Vault

Pradaxa Oral Pellets — Medical Mutual

Deep Vein Thrombosis or Pulmonary Embolism, Treatment

Initial criteria

  • Patient is age ≥ 8 years

Reauthorization criteria

  • Continuation requires response to therapy unless otherwise noted

Approval duration

1 year